Actinogen Total Stockholder Equity from 2010 to 2024
| ACW Stock | 0.02 0 4.00% |
Total Stockholder Equity | First Reported 2006-06-30 | Previous Quarter 12 M | Current Value 19.7 M | Quarterly Volatility 7.5 M |
Check Actinogen Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Actinogen Medical's main balance sheet or income statement drivers, such as Interest Expense of 25.5 K, Selling General Administrative of 1.3 M or Depreciation And Amortization of 244.7 K, as well as many indicators such as . Actinogen financial statements analysis is a perfect complement when working with Actinogen Medical Valuation or Volatility modules.
Actinogen | Total Stockholder Equity |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Actinogen Stock Analysis
When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.